The Mechanism of Action of Lipid-Lowering Drugs

Nestel PJ , and Fidge NH : The physiology of plasma lipoproteins. In: Lipoproteins, Atherosclerosis and Coronary Heart Disease, ed. by Miller NE and Lewis B. Amsterdam, Elsevier/North Holland Biomedical Press , 1981, p. 3.

Brown MS , Kovanen PT and Goldstein JL : Regulation of plasma cholesterol by lipoprotein receptors. Science 212:628, 1981.

Altschul R. , Hoffer A. and Stephen JD : Influence of nicotinic acid on serum cholesterol in man. Arch Biochem Biophys 54:558, 1955.

Krishna G. , Weiss B. , Davies JI , et al: Mechanism of nicotinic acid inhibition of hormone-induced lipolysis . Fed Proc 25:719, 1966.

Nikkila EA : Effects of nicotinic acid on adipose tissue lipoprotein lipase and removal rate of plasma triglycerides. In: Metabolic Effects of Nicotinic Acid and Its Derivatives, ed. by Gey KF and Carlson LA. Bern, Hans Huber, 1971, p. 487.

Nunn SL , Tauxe WN and Juergens JL : Effect of nicotinic acid in human cholesterol biosynthesis. Circ 24:1099, 1981.

Hunninghake DB , and Probstfield JL : Drug treatment of hyperlipidemia. In: Hyperlipidemia: Diagnosis and Therapy, ed. by Rifkind BM and Levy RI. New York, Grune and Stratton, 1977, p. 327.

Carlson LA , Ekelund LG and Oro L. : Clinical and metabolic effects of different doses of prostaglandin E 1 in man: Prostaglandin and related factors. Acta Med Scand 183:423, 1968.

Carlson LA , Walldius G. and Butcher RW : Effect of chlorophenoxyisobutyric acid (CPIB) on rate-mobilizing lipolysis and cyclic AMP levels in rat epididymal fat pads. Atherosclerosis 16:349, 1972.

Maragandakis ME , and Hankin H. : On the mode of action of lipid lowering agents. V. Kinetics of the inhibition in vitro of rat acetyl coA carbosylase. J Biochem 246:348, 1971.

Tarentino AL , Richert DA and Westerfield WW : The concurrent induction of hepatic -glycerophosphate dehydrogenase and ma-late dehydrogenase by thyroid hormone. Biochem Biophys Acta 124:295, 1966.

Gould RG , Swyryd EA , Avoy D. , et al: The effects of -p-chlorophenoxyisobutyrate on the synthesis and release into plasma of lipoproteins in rats. Prog Biochem Pharmacol 2:345, 1957.

Thompson GR : Dietary and pharmacological control of lipoprotein metabolism. In: Lipoproteins, Atherosclerosis and Coronary Heart Disease, ed. by Miller NE and Lewis B. Amsterdam, Elsiever/North Holland Biomed Press, 1981, p. 129.

Wilson DE , and Lees RS : Metabolic relationships among the plasma lipoproteins. J Clin Invent 51:1051, 1972.

Report from the Committee of Principal Investigators: A cooperative trial in the primary prevention of ischemic heart disease using clofibrate . Br Heart J 40:1069, 1978.

Hulley SB , Rosenbaum RH , Bawol RD , et al: Epidemiology as a guide to clinical decisions: the associations between triglyceride and coronary heart disease. NEJM 302:1383, 1980.

The Coronary Drug Project Research Group : Clofibrate and niacin in coronary heart disease. JAMA 231:360, 1975.

Langer T. , and Levy RI : Acute muscular syndrome associated with administration of clofibrate. NEJM 229:856, 1968.

Miettinen TA : Mode of action of a new hypocholesterolemic drug (DH-581) in familial hypercholesterolemia. Atherosclerosis 15:163, 1972.

Barnhart JW , Sefranka JA and McIntosh DD : Hypocholesterolemic effect of 4,4'-(isopropylidenedithio) bis (2,6-di-t-butylphenol) (probucol). Amer J Clin Nutr 23:1229, 1970.

LeLorier J. , DuBreuil-Quidoz S. , Lussier-Cacan S. , et al: Diet and probucol in lowering cholesterol concentrations. Arch Intern Med 137:1429, 1977 .

Enjalbert M. , Lussier-Cacan S. , Dubeuil-Quidoz S. , et al: Usefulness of probucol in treating hypercholesterolemia. Can Med J 123:754, 1980.

Hunninghake DB , Bell D. and Olson L. : Effect of probucol in plasma lipids and lipoproteins in Type IIb hyperlipoproteinemia. Ather 37:469, 1980.

Gagne C. , Lupien PJ , Brun D. , Moorjani S. , et al: Probucol and high-density-lipoprotein cholesterol. Can Med J 123:356, 1980.

Slater HR , Packard CJ , Bicker S. , et al: Effects of cholestyramine on receptor-medicated plasma clearance and tissue uptake of human low-density lipoproteins in the rabbit. J Bio Chem 255:10210, 1980.

Shephard J. , Packard CJ , Bicker S. , et al: Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism. NEJM 302:1219, 1980 .

Levy RI (moderator), Discussants: Dietary and drug treatment of primary hyperlipoproteinemia, NIH conference. Ann Intern Med 77:267, 1972.

Khachadurion A. K: Cholestyramine therapy in patients homozygous for familial hypercholesterolemia. J Ather Res 8:177, 1968.

Clifton-Bligh P. , Miller NE and Nestel PJ : Changes in plasma lipoprotein lipids in hypercholesterolemic patients treated with the bile-sequestering resin, colestipol. Clin Sci Mol Med 47:547, 1974.

Hunninghake DB , Probstfield JL , Crow LO , et al: Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia. Metabolism 30:605, 1981.

Hunninghake DB , Bell C. and Olson L. : Effect of colestipol and clofibrate, singly and in combinations, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia . Metabolism 30:610, 1981.

Boyden TW , and Totman L. : Synergistic effects of probucol and cholestyramine to lower serum cholesterol. J Clin Pharm 21:48, 1981.

Kane JP , Malloy MJ , Tun P. , et al: Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen. NEJM 304:251, 1981.

Illingworth DR , Rapp JH , Phillipson BE , et al: Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolemia. Lancet II:296, 1981.

Mabuchi H. , Haba T. , Tatami R. , et al: Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiguinine-10 levels in patients with familial hypercholesterolemia. NEJM 305:478, 1981.

Kissenbah AH , Adams PA and Wynn V. : Lipokinetic studies with gemfibrozil (CI-719) . Proc R Soc Med (Suppl)2:94, 1976.

Kaukola S. , Manninen V. , Malkonen M. , et al: Gemfibrozil in the treatment of dyslipidemias in middle-aged male survivors of myocardial infarction. Acta Med Scand 209:69, 1981.